Medpace Holdings Inc Live Stock Price Today, Share Analysis and Chart

Name: Medpace Holdings Inc: Is Infosys Ltd. worth buying?
Item: Medpace Holdings Inc
Rating: 1.89620825
Author: Trendlyne DVM scores

Momentum Trap

about

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including ...

612.05 9.35 (1.55%)

64.09% Gain from 52W Low

159.8K

XNAS Volume

XNAS 09 Oct, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Medpace Holdings Inc is on 22 Oct 2026 for the purpose of Medpace Holdings Inc Third Quarter Earnings Results for 2026 See details

Low Financial Strength

33.3 / 100

Expensive Valuation

25.0 / 100

Technically Moderately Bullish

60.0 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution View Similar Embed DVM

596

1Yr Price target downside is -3%

13 analysts

Medpace Holdings Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Medpace Holdings Inc Live Stock Price Today, Share Analysis and Chart

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including ...

64.09% Gain from 52W Low

SWOT Analysis

Medpace Holdings Inc Live Price Chart

Medpace Holdings Inc Live Price Chart